{"slug":"australia","tag":"australia","variants":["australia"],"description":"No description yet","count":11,"kinds":{"person":11},"related":[{"slug":"cll","tag":"cll","shared":2},{"slug":"venetoclax","tag":"venetoclax","shared":2},{"slug":"aml","tag":"aml","shared":1},{"slug":"bispecific","tag":"bispecific","shared":1},{"slug":"btk","tag":"btk","shared":1},{"slug":"cervical","tag":"cervical","shared":1},{"slug":"cml","tag":"cml","shared":1},{"slug":"cooperative-group","tag":"cooperative-group","shared":1},{"slug":"immunotherapy","tag":"immunotherapy","shared":1},{"slug":"kidney","tag":"kidney","shared":1},{"slug":"leadership","tag":"leadership","shared":1},{"slug":"lymphoma","tag":"lymphoma","shared":1}],"records":[{"id":"anthony-lawler","kind":"person","name":"Anthony Lawler","route":"/people/anthony-lawler/","tldr":"Head of Australia's medicines and medical devices regulator, the body that approves cancer drugs for the Australian market."},{"id":"louise-emmett","kind":"person","name":"Louise Emmett","route":"/people/louise-emmett/","tldr":"Nuclear medicine physician who leads ENZA-p and the PSMA imaging trials shaping Australian theranostics."},{"id":"linda-mileshkin","kind":"person","name":"Linda Mileshkin","route":"/people/linda-mileshkin/","tldr":"Led OUTBACK, which showed adding chemotherapy after chemoradiation does not help cervical cancer, a key negative result."},{"id":"georgina-long","kind":"person","name":"Georgina V. Long","route":"/people/georgina-long/","tldr":"Melanoma trialist who led COMBI-d, COMBI-AD and NADINA, moving immunotherapy before surgery for stage III disease."},{"id":"anna-nowak","kind":"person","name":"Anna K. Nowak","route":"/people/anna-nowak/","tldr":"Australian oncologist who led DREAM and DREAM3R, testing durvalumab with chemotherapy in mesothelioma."},{"id":"andrew-wei","kind":"person","name":"Andrew H. Wei","route":"/people/andrew-wei/","tldr":"Australian haematologist who led VIALE-C and QUAZAR AML-001, advancing venetoclax and oral azacitidine maintenance in AML."},{"id":"timothy-hughes","kind":"person","name":"Timothy P. Hughes","route":"/people/timothy-hughes/","tldr":"Defined molecular response monitoring in CML and showed that many patients can safely stop imatinib."},{"id":"michael-dickinson","kind":"person","name":"Michael Dickinson","route":"/people/michael-dickinson/","tldr":"Led the pivotal glofitamab trial, establishing off-the-shelf bispecific antibodies for relapsed large B-cell lymphoma."},{"id":"john-seymour","kind":"person","name":"John F. Seymour","route":"/people/john-seymour/","tldr":"Led MURANO, which established venetoclax plus rituximab as fixed-duration therapy for relapsed CLL."},{"id":"constantine-tam","kind":"person","name":"Constantine S. Tam","route":"/people/constantine-tam/","tldr":"Led the zanubrutinib SEQUOIA trial and the first ibrutinib-venetoclax study in mantle cell lymphoma."},{"id":"shankar-siva","kind":"person","name":"Shankar Siva","route":"/people/shankar-siva/","tldr":"Radiation oncologist who established stereotactic radiotherapy as a non-surgical option for primary kidney cancer."}]}